EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Small molecule inhibition of the mitochondrial lipid transfer protein STARD7 attenuates influenza viral replication

Shipra Sharma, Oyahida Khatun, Jihaan Adonis, Shaochen You, Kevin Hartenbower, Vedita Anand Singh, Namir Shaabani, Saikat De, Emi R Matsuo, Rachel Y Sattler, Jonathan A Covel, Kris M White und 12 weitere

PLOS Pathogens · 2026

DOI: 10.1371/journal.ppat.1013914 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2026. Verfasst von Shipra Sharma und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America. Hauptthemen laut MEDLINE: Virus Replication, Influenza A virus, Carrier Proteins, Antiviral Agents. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIAID NIH HHS, U.S. Department of Defense.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The increasing appearance of drug-resistant and zoonotic influenza strains highlights an urgent need for host-directed antivirals that offer broad-spectrum activity and a higher barrier to resistance. Here, we describe the characterization of M4, a small-molecule identified from a high-throughput screen that potently inhibits influenza A and B viruses. Mechanistic studies reveal that M4 suppresses influenza virus replication by preventing formation of export-competent viral ribonucleoprotein (vRNP) complexes in the nucleus. Chemoproteomic profiling identified the lipid transfer protein STARD7 as the primary cellular target, and genetic depletion of STARD7 phenocopies the antiviral effects of M4. Additional studies localized the M4 binding site to cysteine 302 within the lipid-binding domain of STARD7, supporting a model in which STARD7-dependent lipid transfer activity promotes efficient vRNP assembly and nuclear export. Combining M4 with baloxavir enhances antiviral efficacy in a murine infection model, providing in vivo support for a host-directed therapeutic strategy. Together, these results identify STARD7 as a metabolic checkpoint licensing vRNP nuclear export and they establish a proof of concept for therapeutic intervention with small molecule inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Virus ReplicationInfluenza A virusCarrier ProteinsAntiviral AgentsOrthomyxoviridae InfectionsInfluenza B virusAnimalsHumansMice

Substanzen

Carrier ProteinsAntiviral Agents

Autor:innen und Institutionen

  • Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.
  • Calibr, a Division of The Scripps Research Institute, La Jolla, California, United States of America.
  • Department of Medical Biosciences, University of the Western Cape, Bellville, Cape Town, South Africa.
  • Department of Chemistry, Scripps Research, San Diego, California, United States of America.
  • Conrad Prebys Center for Chemical Genomics, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, United States of America.
  • Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.

ORCID-Profile: Malina A Bakowski, Dylan J Mendonsa, Sumit K Chanda

Förderung

  • NIH HHS
  • NIAID NIH HHS
  • U.S. Department of Defense
  • Division of Intramural Research, National Institute of Allergy and Infectious Diseases
  • Advanced Research Projects Agency for Health

Zitieren

APA

Sharma, S., Khatun, O., Adonis, J., You, S., Hartenbower, K., Singh, V. A., Shaabani, N., De, S., Matsuo, E. R., Sattler, R. Y., Covel, J. A., White, K. M., Martin-Sancho, L., Bakowski, M. A., Mendonsa, D. J., Mehta, A., Yassir, N. S., Olson, S. H., Matsunaga, N., …, & Chanda, S. K. (2026). Small molecule inhibition of the mitochondrial lipid transfer protein STARD7 attenuates influenza viral replication. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1013914

Vancouver

Sharma S, Khatun O, Adonis J, You S, Hartenbower K, Singh VA, et al. Small molecule inhibition of the mitochondrial lipid transfer protein STARD7 attenuates influenza viral replication. PLOS Pathogens. 2026. doi:10.1371/journal.ppat.1013914

BibTeX
@article{Sharma2026,
  author = {Sharma, Shipra and Khatun, Oyahida and Adonis, Jihaan and You, Shaochen and Hartenbower, Kevin and Singh, Vedita Anand and Shaabani, Namir and De, Saikat and Matsuo, Emi R and Sattler, Rachel Y and Covel, Jonathan A and White, Kris M and Martin-Sancho, Laura and Bakowski, Malina A and Mendonsa, Dylan J and Mehta, Ayush and Yassir, Noura S and Olson, Steven H and Matsunaga, Naoko and García-Sastre, Adolfo and Bollong, Michael J and Farhat, Nisar A and Shaw, Megan L and Chanda, Sumit K},
  title = {Small molecule inhibition of the mitochondrial lipid transfer protein STARD7 attenuates influenza viral replication},
  journal = {PLOS Pathogens},
  year = {2026},
  doi = {10.1371/journal.ppat.1013914}
}
Kostenlos starten →